329 related articles for article (PubMed ID: 12917505)
1. Correlation between serum resistin level and adiposity in obese individuals.
Azuma K; Katsukawa F; Oguchi S; Murata M; Yamazaki H; Shimada A; Saruta T
Obes Res; 2003 Aug; 11(8):997-1001. PubMed ID: 12917505
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.
Lewandowski KC; Szosland K; O'Callaghan C; Tan BK; Randeva HS; Lewinski A
Mol Genet Metab; 2005 May; 85(1):61-9. PubMed ID: 15862282
[TBL] [Abstract][Full Text] [Related]
3. [The relationship between human serum resistin level and body fat content, plasma glucose as well as blood pressure].
Zhang J; Qin Y; Zheng X; Qiu J; Gong L; Mao H; Jia W; Guo J
Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1609-12. PubMed ID: 12667367
[TBL] [Abstract][Full Text] [Related]
4. Relationship between serum resistin concentration and proinflammatory cytokines in obese women with impaired and normal glucose tolerance.
Janowska J; Zahorska-Markiewicz B; Olszanecka-Glinianowicz M
Metabolism; 2006 Nov; 55(11):1495-9. PubMed ID: 17046552
[TBL] [Abstract][Full Text] [Related]
5. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance.
Monzillo LU; Hamdy O; Horton ES; Ledbury S; Mullooly C; Jarema C; Porter S; Ovalle K; Moussa A; Mantzoros CS
Obes Res; 2003 Sep; 11(9):1048-54. PubMed ID: 12972674
[TBL] [Abstract][Full Text] [Related]
6. [Reduced resistin levels in patients with type 2 diabetes mellitus].
Yang J; Li M; Wu CY; Wang H; Xu QS; Deng JY
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1471-4. PubMed ID: 14521723
[TBL] [Abstract][Full Text] [Related]
7. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.
Vendrell J; Broch M; Vilarrasa N; Molina A; Gómez JM; Gutiérrez C; Simón I; Soler J; Richart C
Obes Res; 2004 Jun; 12(6):962-71. PubMed ID: 15229336
[TBL] [Abstract][Full Text] [Related]
8. Increase in serum resistin during weight loss in overweight subjects is related to lipid metabolism.
Koebnick C; Wagner K; Garcia AL; Gruendel S; Lahmann PH; Weickert MO; Möhlig M; Harsch IA; Einig C; Speth M; Katz N; Trippo U; Zunft HJ
Int J Obes (Lond); 2006 Jul; 30(7):1097-103. PubMed ID: 16477272
[TBL] [Abstract][Full Text] [Related]
9. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters.
Chen CC; Li TC; Li CI; Liu CS; Wang HJ; Lin CC
Metabolism; 2005 Apr; 54(4):471-5. PubMed ID: 15798953
[TBL] [Abstract][Full Text] [Related]
10. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss.
Milan G; Granzotto M; Scarda A; Calcagno A; Pagano C; Federspil G; Vettor R
Obes Res; 2002 Nov; 10(11):1095-103. PubMed ID: 12429872
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
12. Serum resistin is not associated with obesity or insulin resistance in humans.
Iqbal N; Seshadri P; Stern L; Loh J; Kundu S; Jafar T; Samaha FF
Eur Rev Med Pharmacol Sci; 2005; 9(3):161-5. PubMed ID: 16080635
[TBL] [Abstract][Full Text] [Related]
13. Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity.
Hasegawa G; Ohta M; Ichida Y; Obayashi H; Shigeta M; Yamasaki M; Fukui M; Yoshikawa T; Nakamura N
Acta Diabetol; 2005 Jun; 42(2):104-9. PubMed ID: 15944845
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance.
Pfützner A; Langenfeld M; Kunt T; Löbig M; Forst T
Clin Lab; 2003; 49(11-12):571-6. PubMed ID: 14651328
[TBL] [Abstract][Full Text] [Related]
15. Is dermolipectomy effective in improving insulin action and lowering inflammatory markers in obese women?
Rizzo MR; Paolisso G; Grella R; Barbieri M; Grella E; Ragno E; Grella R; Nicoletti G; D'Andrea F
Clin Endocrinol (Oxf); 2005 Sep; 63(3):253-8. PubMed ID: 16117810
[TBL] [Abstract][Full Text] [Related]
16. [Serum adiponectin concentration in relation to body fat distribution and tissue insulin sensitivity in the glucose clamp study].
Chen L; Xiang KS; Jia WP; Lu JX; Bao YQ; Lu HJ
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1456-9. PubMed ID: 16061021
[TBL] [Abstract][Full Text] [Related]
17. Amylin and its relation to insulin and lipids in obese children before and after weight loss.
Reinehr T; de Sousa G; Niklowitz P; Roth CL
Obesity (Silver Spring); 2007 Aug; 15(8):2006-11. PubMed ID: 17712118
[TBL] [Abstract][Full Text] [Related]
18. Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity.
Kim C; Park J; Park J; Kang E; Ahn C; Cha B; Lim S; Kim K; Lee H
Obesity (Silver Spring); 2006 Jul; 14(7):1164-71. PubMed ID: 16899797
[TBL] [Abstract][Full Text] [Related]
19. Relationships between human serum resistin, inflammatory markers and insulin resistance.
Bo S; Gambino R; Pagani A; Guidi S; Gentile L; Cassader M; Pagano GF
Int J Obes (Lond); 2005 Nov; 29(11):1315-20. PubMed ID: 16044175
[TBL] [Abstract][Full Text] [Related]
20. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance.
Hana V; Silha JV; Justova V; Lacinova Z; Stepan JJ; Murphy LJ
Clin Endocrinol (Oxf); 2004 Apr; 60(4):442-50. PubMed ID: 15049958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
